WPI 22 26 (Desmopressin 0.2 mg)
Pill imprint WPI 22 26 has been identified as Desmopressin acetate 0.2 mg.
Desmopressin is used in the treatment of primary nocturnal enuresis; diabetes insipidus; von willebrand's disease; hemophilia a and belongs to the drug class antidiuretic hormones. There is no proven risk in humans during pregnancy. Desmopressin 0.2 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- WPI 22 26
- Strength:
- 0.2 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Antidiuretic hormones
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Watson Pharmaceuticals, Inc.
- National Drug Code (NDC):
- 00591-2226
More about desmopressin
Consumer resources
- Desmopressin
- Desmopressin solution
- Desmopressin spray
- Desmopressin tube
- Desmopressin injection
- More (4) »
- Other brands: DDAVP, Minirin, Stimate, DDAVP Rhinal Tube
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
